Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBloomsbury Regulatory News (BMY)

Share Price Information for Bloomsbury (BMY)

Share Price is delayed by 15 minutes
Get Live Data
663.00    -2.00 (-0.30%)
Bid:
662.00
Ask:
665.00
Spread: 3.00 (0.453%)
Market Cap: £539.65m
BMY Live PriceLast checked at - London Stock Exchange

Intraday Bloomsbury Share Chart

Trading Statement

15 Jan 2009 07:00

RNS Number : 6659L
Bloomsbury Publishing PLC
15 January 2009
 

Bloomsbury Publishing Plc

("Bloomsbury" or "the Group")

Trading Statement

 

Bloomsbury Publishing announces that 2008 trading was in line with management's expectations

 Bloomsbury published the two highest selling books of the year in the Times list of Top Bestsellers of 2008 and three of the top tenA Thousand Splendid Suns was number one, The Tales of Beedle the Bard number two, and The Kite Runner number eight.

 Sales were good in difficult market conditions driven by a strong publishing programme which included The Kite Runner and A Thousand Splendid Suns by Khaled Hosseini; JK Rowling's The Tales of Beedle The Bardon behalf of her charity, The Children's High Level Group; The Snowball - Warren Buffett and the Business of Life by Alice Schroeder; The Suspicions of Mr Whicher by Kate Summerscale; The Big Fat Duck Cookbook by Heston Blumenthal; Just Me by Sheila Hancock; and The Graveyard Book by Neil Gaiman. Rights dealsincluding Qatar Finance - The Ultimate Resource and the publishing partnership with Qatar Foundation also contributed to the year. The Group made four acquisitions in 2008: Featherstone, Berg, John Wisden and The Arden Shakespeare, and launched one new division, Bloomsbury Academic.

Period-end cash for the Group is likely to be in excess of £50mIn 2009 investment income will decline in line with the decrease in the UK bank base rate. We are mindful of the impact of the uncertainty in the global economy on the book publishing market, though it is not clear at this stage what the quantum of that impact will be. A handful of customers have already closed or are in administration but books have been reasonably resilient in previous economic downturns. Over the past two years, Bloomsbury has concluded database and management licences and contracts with leading organisations which, because they are long-term in nature, will provide greater certainty of cash flow and profit stability for the Group for the next five years.  

The preliminary results for the year ended 31st December 2008 will be announced on 31st March 2009.

 

-ends-

 

Enquiries

Bell Pottinger - Dan de Belder / Rosanne Perry 020 7861 3232 

 

Notes to Editors:

About Bloomsbury Publishing Plc 

(www.bloomsbury.com and www.bloomsbury-ir.co.uk) 

 

Bloomsbury Publishing is one of the world's leading independent, publicly quoted publishing houses with an invaluable catalogue of authors including Margaret Atwood, Heston Blumenthal, Hugh Fearnley-Whittingstall David Guterson, Khaled Hosseini, John Irving, and J.K. Rowling. In addition, Bloomsbury publishes essential digital reference works, databases and information resources including Schott's Miscellanies and Almanacs, Who's Who, Whitaker's Almanack, Wisden Cricketers' Almanack, Reed's Nautical Almanac, Black's Medical Dictionary, Business: The Ultimate Resource, Qatar Finance: The Ultimate Resource, The Arden Shakespeare and the Berg Fashion Library.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKGGMMNDLGLZM
Date   Source Headline
8th Jun 20263:20 pmRNSHolding(s) in Company
22nd May 20268:38 amRNSHolding(s) in Company
20th May 20267:00 amRNSAppointment of Non-Executive Director
20th May 20267:00 amRNSAudited Preliminary Results
12th May 20267:00 amRNSNotice of Preliminary Results
30th Apr 20262:47 pmRNSHolding(s) in Company
23rd Apr 202612:25 pmRNSHolding(s) in Company
15th Apr 202612:49 pmRNSAppointment of Executive Director - Replacement
15th Apr 20267:00 amRNSAppointment of Executive Director
1st Apr 20269:00 amRNSHolding(s) in Company
24th Mar 20267:22 amRNSHolding(s) in Company
19th Mar 20261:15 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading Update
18th Feb 20265:51 pmRNSHolding(s) in Company
13th Feb 202610:21 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Feb 20264:39 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNS-RBloomsbury to grow Academic sales in Asia
8th Dec 202510:05 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSGoogle and Bloomsbury Strategic Collaboration
19th Nov 202511:53 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSUnaudited Interim Results
8th Oct 20257:00 amRNS-RAuthor Katherine Rundell announces multi-film deal
2nd Oct 20255:22 pmRNSHolding(s) in Company
22nd Sep 20254:20 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSAppointment of Chief Financial & Operating Officer
29th Aug 20253:39 pmRNSDirector/PDMR Shareholding
28th Aug 20254:16 pmRNSDirector/PDMR Shareholding
28th Aug 20253:51 pmRNSDirector/PDMR Shareholding
15th Aug 20259:34 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Aug 202512:11 pmRNSDirector/PDMR Shareholdings - Correction
12th Aug 20254:29 pmRNSDirector/PDMR Shareholding
11th Aug 202511:08 amRNSDirector/PDMR Shareholding
5th Aug 202511:31 amRNSHolding(s) in Company
1st Aug 20251:14 pmRNSDirector/PDMR Shareholding
31st Jul 202511:10 amRNSDirector/PDMR Shareholding
30th Jul 20253:55 pmRNSHolding(s) in Company
29th Jul 20253:08 pmRNSHolding(s) in Company
28th Jul 20254:39 pmRNSHolding(s) in Company
25th Jul 20253:13 pmRNSHolding(s) in Company
24th Jul 20253:48 pmRNSHolding(s) in Company
17th Jul 20253:46 pmRNSHolding(s) in Company
16th Jul 20253:16 pmRNSResults of the 2025 Annual General Meeting
16th Jul 20257:00 amRNSAGM Trading Update
15th Jul 20254:14 pmRNSHolding(s) in Company
4th Jul 20253:54 pmRNSHolding(s) in Company
2nd Jul 20254:39 pmRNSHolding(s) in Company
13th Jun 20255:33 pmRNSAnnual Financial Report
22nd May 20257:00 amRNSAnnual Financial Report
15th May 20257:00 amRNSNotice of Preliminary Results
15th Apr 20257:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.